30 results on '"Legnani, Cristina"'
Search Results
2. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
3. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
4. Edoxaban plasma levels in patients with non-valvular atrial fibrillation: Inter and intra-individual variability, correlation with coagulation screening test and renal function
5. Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs
6. Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack
7. Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
8. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis
9. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics
10. D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis
11. Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant
12. D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome
13. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum)
14. Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia
15. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale
16. The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis
17. Risk of early recurrent fetal loss and levels of thrombin-activatable fibrinolysis inhibitor
18. No early signs of atherosclerotic alterations in carriers of inherited thrombophilia
19. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil® D-dimer HS 500, in patients with clinically suspected venous thromboembolism
20. Membrane binding and anticoagulant properties of protein S natural variants
21. Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY)
22. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
23. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis
24. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans
25. Comparative evaluation of d-dimer assays for exclusion of deep venous thrombosis in symptomatic outpatients
26. A new rapid bedside assay for quantitative testing of D-Dimer (Cardiac D-Dimer) in the diagnostic work-up for deep vein thrombosis
27. Evaluation of activated protein C resistance in stored plasma
28. Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis
29. Fibrinolytic tests and venous thrombophilia
30. Blood coagulation changes in homocystinuria: Effects of pyridoxine and other specific therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.